HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Suzuki Selected Research

alpha-tocopherol transfer protein

3/2014Alpha-tocopherol transfer protein gene inhibition enhances the acquired immune response during malaria infection in mice.
4/2010Alpha-tocopherol transfer protein disruption confers resistance to malarial infection in mice.
1/2010alpha-Tocopherol transfer protein inhibition is effective in the prevention of cerebral malaria in mice.
11/2009The effect of alpha-tocopherol transfer protein gene disruption on Trypanosoma congolense infection in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Suzuki Research Topics

Disease

57Infections
12/2021 - 01/2002
36Human Influenza (Influenza)
05/2020 - 01/2002
27Myocardial Infarction
04/2022 - 06/2003
26Neoplasms (Cancer)
10/2020 - 05/2002
25Gout
01/2022 - 11/2009
18Breast Neoplasms (Breast Cancer)
01/2019 - 09/2004
17Hyperuricemia
01/2022 - 12/2011
16Inflammation (Inflammations)
01/2022 - 03/2004
13Fibrosis (Cirrhosis)
01/2022 - 02/2006
11Body Weight (Weight, Body)
04/2022 - 06/2003
11Heart Failure
01/2022 - 04/2005
11Malaria
03/2019 - 05/2007
10Stroke (Strokes)
01/2022 - 10/2008
10Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 05/2002
9Atherosclerosis
01/2019 - 03/2002
8Thrombosis (Thrombus)
02/2022 - 07/2003
8Hypertension (High Blood Pressure)
01/2022 - 01/2003
7Hemorrhage
04/2022 - 01/2019
7Dyslipidemias (Dyslipidemia)
01/2022 - 04/2006
7Hepatocellular Carcinoma (Hepatoma)
03/2017 - 05/2002
7Chronic Hepatitis C
10/2011 - 01/2002
6Pathologic Constriction (Stenosis)
01/2022 - 05/2002
6Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2006
6ST Elevation Myocardial Infarction
04/2021 - 08/2013
6Parasitemia
03/2020 - 01/2010
6Coronary Disease (Coronary Heart Disease)
01/2019 - 12/2002
6Hyperplasia
12/2018 - 02/2006
6Ischemia
06/2016 - 10/2005
6Neointima
01/2014 - 09/2002
6Liver Diseases (Liver Disease)
10/2012 - 01/2003
5Spasm (Spasms)
01/2022 - 08/2008
5Heart Diseases (Heart Disease)
01/2021 - 06/2003
5Chromosome Aberrations (Chromosome Abnormalities)
12/2018 - 08/2011
5Neoplasm Metastasis (Metastasis)
11/2014 - 09/2008
5Fever (Fevers)
12/2012 - 02/2008
5Cholestasis
02/2011 - 09/2006
5Carcinogenesis
12/2009 - 02/2003
4Atrial Fibrillation
07/2022 - 08/2009
4Atherosclerotic Plaque (Atheroma)
02/2022 - 01/2016
4Acute Coronary Syndrome
01/2022 - 04/2006
4Unstable Angina
01/2022 - 08/2017
4Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2022 - 07/2003
4Death (Near-Death Experience)
01/2022 - 01/2019
4Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2014
4Necrosis
12/2020 - 11/2005
4Non-alcoholic Fatty Liver Disease
12/2019 - 10/2011
4Hyperlipidemias (Hyperlipidemia)
01/2019 - 09/2003
4Disease Progression
01/2019 - 02/2008
4Chronic Limb-Threatening Ischemia
01/2017 - 11/2008

Drug/Important Bio-Agent (IBA)

38Proteins (Proteins, Gene)FDA Link
01/2019 - 10/2003
21Uric Acid (Urate)IBA
01/2022 - 11/2009
20Pharmaceutical PreparationsIBA
01/2021 - 01/2002
14Antiviral Agents (Antivirals)IBA
12/2018 - 01/2003
13Amantadine (Aman)FDA LinkGeneric
04/2010 - 01/2002
12Oseltamivir (Tamiflu)FDA Link
01/2017 - 09/2003
11CholesterolIBA
08/2020 - 12/2002
9CytokinesIBA
01/2022 - 04/2005
9DNA (Deoxyribonucleic Acid)IBA
12/2021 - 12/2002
9urate transporterIBA
11/2021 - 01/2013
9AntigensIBA
05/2020 - 01/2003
9ASP2151IBA
12/2018 - 08/2010
8Vitamin EFDA LinkGeneric
06/2021 - 11/2009
8oxidized low density lipoproteinIBA
01/2014 - 12/2002
7DNA Primase (Primase)IBA
12/2018 - 08/2010
7ErythropoietinFDA Link
01/2018 - 06/2006
7CollagenIBA
12/2017 - 02/2006
7EnzymesIBA
03/2016 - 05/2003
7Messenger RNA (mRNA)IBA
08/2015 - 10/2004
7Zanamivir (Relenza)FDA Link
01/2014 - 12/2002
6Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2003
6AntibodiesIBA
01/2020 - 03/2002
6LipidsIBA
03/2019 - 09/2003
6ImmunosorbentsIBA
03/2016 - 12/2003
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2015 - 04/2006
6Neuraminidase (Sialidase)IBA
01/2014 - 10/2004
6Multidrug Resistance-Associated Protein 2IBA
02/2013 - 05/2002
6Scavenger Receptors (Scavenger Receptor)IBA
06/2010 - 03/2002
5Phenobarbital (Luminal)FDA Link
02/2022 - 05/2002
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022 - 09/2005
5Angiotensin Receptor AntagonistsIBA
01/2022 - 09/2006
5ATP-Binding Cassette Transporters (ABC Transporters)IBA
11/2021 - 01/2003
5Ezetimibe (Zetia)FDA Link
08/2020 - 02/2015
5Glucose (Dextrose)FDA LinkGeneric
01/2020 - 04/2006
5Tocopherols (Tocopherol)IBA
03/2019 - 11/2011
5Probucol (Lorelco)FDA Link
03/2019 - 01/2015
5Valacyclovir (Valtrex)FDA LinkGeneric
12/2018 - 08/2010
5Peptides (Polypeptides)IBA
01/2017 - 09/2005
5InterferonsIBA
12/2014 - 01/2002
42'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
04/2022 - 10/2017
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 09/2016
4Biological ProductsIBA
01/2021 - 06/2006
4Insulin (Novolin)FDA Link
01/2020 - 01/2009
4Glutathione (Reduced Glutathione)IBA
01/2017 - 10/2011

Therapy/Procedure

40Therapeutics
04/2022 - 12/2002
15Stents
01/2022 - 05/2002
10Percutaneous Coronary Intervention
01/2022 - 08/2013
9Drug Therapy (Chemotherapy)
03/2022 - 09/2004
5Aftercare (After-Treatment)
01/2021 - 02/2008
4Catheter Ablation
07/2022 - 07/2017
4Drug-Eluting Stents
04/2022 - 05/2013